Systematic Quantitative Analysis of Fetal Dexamethasone Exposure and Fetal Lung Maturation in Pregnant Animals: Model Informed Dexamethasone Precision Dose Study.


Journal

ACS pharmacology & translational science
ISSN: 2575-9108
Titre abrégé: ACS Pharmacol Transl Sci
Pays: United States
ID NLM: 101721411

Informations de publication

Date de publication:
14 Jun 2024
Historique:
received: 28 12 2023
revised: 13 03 2024
accepted: 15 03 2024
pmc-release: 14 05 2025
medline: 20 6 2024
pubmed: 20 6 2024
entrez: 20 6 2024
Statut: epublish

Résumé

Dexamethasone (DEX) was applied in neonatal respiratory distress syndrome treatment of pregnant women. We established a pharmacokinetics (PK)/pharmacodynamics(PD)/end point model of pregnant animals based on published data and then extrapolated to simulate fetal exposure and lung maturation in pregnant women. We first established the PK/PD/end point model for DEX in pregnant sheep. We considered the competitive effect of cortisol (Cort) and DEX binding with glucocorticoid receptor and then used the indirect response model to describe disaturated-phosphatidylcholine (DSPC) dynamics. Based on that, we established a regression relationship between DSPC and fetal lung volume (V40). We then extrapolated the PD/end point model of pregnant sheep to pregnant monkeys by corrected stages of morphologic lung maturation in two species. Finally, we utilized the interspecies extrapolation strategy to simulate fetal exposure (AUC

Identifiants

pubmed: 38898943
doi: 10.1021/acsptsci.3c00391
pmc: PMC11184600
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1770-1782

Informations de copyright

© 2024 The Authors. Published by American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Auteurs

Ling Song (L)

Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.
Drug Clinical Trial Center, Peking University Third Hospital, Beijing 100191, China.

Jie Song (J)

Drug Clinical Trial Center, Peking University Third Hospital, Beijing 100191, China.

Ying Wang (Y)

Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.

Yuan Wei (Y)

Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.

Yangyu Zhao (Y)

Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.

Dongyang Liu (D)

Drug Clinical Trial Center, Peking University Third Hospital, Beijing 100191, China.
Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China.

Classifications MeSH